InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on KSTP-TV (ABC) and KMSP-TV (FOX) in Minneapolis To Discuss Paralyzing Injuries To Local High School Hockey Players

CAMBRIDGE, Mass. (January 18, 2012) – InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on Minneapolis’ ABC affiliate, KSTP-TV, on Sunday, January 15th during the 8:00 AM (CST) newscast and the FOX affiliate, KMSP-TV, on Monday, January 16th during their 8:00 AM (CST) newscast.

InVivo Therapeutics has pioneered a new treatment platform that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after a traumatic spinal cord injury. Reynolds will discuss the scaffold and how it is expected to work in humans, as well as results from InVivo’s largest non-human primate study.

“The recent spinal cord injuries of two local high school hockey players magnify the need for SCI treatments. Our therapeutic approach confirms a clear paradigm shift in the care of such injuries and we expect that our technology will change the standard treatment for SCI,” said Reynolds. “We’re currently under review at FDA and we look forward to receiving approval to begin human studies. Having worked in conjunction with the Boston Bruins Foundation and with hockey players injured in New England, we understand the needs that these players and their families will have, and we look forward to helping in any way that we can.”

KMSP-TV is the local FOX affiliate and KSTP-TV is the local ABC affiliate in Minneapolis.

Print PDF